Global Liquid Biopsy Market by Products & Services, Sample, Application, End User and by Geography - Trends and Forecast to 2025

Global Liquid Biopsy Market by Products & Services, Sample, Application, End User and by Geography - Trends and Forecast to 2025

Liquid biopsy gained popularity among physicians owing to increasing importance of precision medicine and advantages offered by the liquid biopsy over conventional biopsy techniques. Clinical diagnosis of tumors is done by pathological testing and medical imaging in which pathological testing involves tissue biopsies, molecular pathology tests, and serological indicators tests. Among these techniques tissue biopsy is considered as a gold standard for diagnosis. However, it has certain disadvantages such as difficulty in obtaining tissues from terminal cancer patients, complications due to sampling, and result difference due to tumor heterogeneity. Liquid biopsy provides more accurate results and offers more advantages over conventional techniques. It uses circulating tumor cell detection and cell free DNA etc. techniques for early detection of the cancer.
Market Dynamics
Factors such as rising prevalence of various cancers, rising demand for minimally invasive procedures, and advantages offered by liquid biopsy over conventional tissue biopsy are supporting growth of the liquid biopsy market. Liquid biopsy offers advantages over conventional tissue biopsy such as early disease detection, real-time monitoring of the metastasis and actual treatment response, detection of primary tumors and metastasis through simple and non-invasive tests, and may be cheaper than conventional biopsy. Furthermore, prevalence of various cancers is increasing and according to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer are diagnosed in the U.S., with an around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024, indicating need for early disease diagnosis and treatment. Demand for minimally invasive treatments is also increasing as tissue biopsy is an invasive approach for cancer diagnosis, wherein, liquid biopsy is more convenient, which is expected to boost growth of the liquid biopsy market.
Key features of the study:

This report provides in-depth analysis of liquid biopsy market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global liquid biopsy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Illumina, Inc., Roche AG, Natera, Inc., Laboratory Corporation of America Holdings (LabCorp), Qiagen N.V., Thermo Fisher Scientific Inc., Exact Sciences Corp., Biocept, Inc., Genomic Health, Inc., Guardant Health, TrovaGene Inc., CareDx Inc., Adaptive Biotechnologies Corporation, and Biocartis SA.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global liquid biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the liquid biopsy market

Detailed Segmentation:

Global Liquid Biopsy Market, By Products & Services:

Reagents & Kits     
Equipments
Services

Global Liquid Biopsy Market, By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

Global Liquid Biopsy Market, By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

Global Liquid Biopsy Market, By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

Global Liquid Biopsy Market, By Geography:

North America

By Product & Services:

Reagents & Kits     
Equipments
Services

By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

By Country:

U.S.
Canada

Europe

By Product & Services:

Reagents & Kits     
Equipments
Services

By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Product & Services:

Reagents & Kits     
Equipments
Services

By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Product & Services:

Reagents & Kits     
Equipments
Services

By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

By Country:

Brazil
Mexico
Rest of Latin America

Middle East

By Product & Services:

Reagents & Kits     
Equipments
Services

By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product & Services:

Reagents & Kits     
Equipments
Services

By Sample:

Cell Free DNA (cfDNA)      
Circulating Tumor Cells (CTC)
Exosomes

By Application:

Oncology Testing
Noninvasive Prenatal Testing
Transplant Care     

By End User:

Hospitals     
Research Laboratories
Diagnostic Laboratories
Patients

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Roche AG *

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Illumina, Inc.
Natera Inc.
Laboratory Corporation of America Holdings
Qiagen N.V.
Thermo Fisher Scientific
Exact Sciences Corp.
Biocept, Inc.
Genomic Health, Inc.
Guardant Health
CareDx Inc.
Adaptive Biotechnologies Corporation
Biocartis SA.

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Products & Services
Market Snippet, By Sample
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
PEST Analysis
Porter’s Five Forces Analysis
Regulatory Scenario
Technological Evolution
Mergers & Acquisition
Pipeline Analysis
Recently Launched Products
4. Global Liquid Biopsy Market, By Products & Services, 2017–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Reagents & Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Equipments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
5. Global Liquid Biopsy Market, By Sample, 2017–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Cell Free DNA (cfDNA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Circulating Tumor Cells (CTC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Exosomes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
6. Global Liquid Biopsy Market, By Application, 2017–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Oncology Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Noninvasive Prenatal Testing (NIPT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Transplant Care
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
7. Global Liquid Biopsy Market, By End User, 2017–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017–2025
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Research Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
Patients
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
8. Global Liquid Biopsy Market, By Regions, 2017–2025 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2025
North America
Market Size and Forecast, By Products & Services, 2017–2025 (US$ Mn)
Market Size and Forecast, By Sample, 2017–2025 (US$ Mn)
Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Products & Services, 2017–2025 (US$ Mn)
Market Size and Forecast, By Sample, 2017–2025 (US$ Mn)
Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Products & Services, 2017–2025 (US$ Mn)
Market Size and Forecast, By Sample, 2017–2025 (US$ Mn)
Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Products & Services, 2017–2025 (US$ Mn)
Market Size and Forecast, By Sample, 2017–2025 (US$ Mn)
Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
Brazil
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Products & Services, 2017–2025 (US$ Mn)
Market Size and Forecast, By Sample, 2017–2025 (US$ Mn)
Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Products & Services, 2017–2025 (US$ Mn)
Market Size and Forecast, By Sample, 2017–2025 (US$ Mn)
Market Size and Forecast, By Application, 2017–2025 (US$ Mn)
Market Size and Forecast, By End User, 2017–2025 (US$ Mn)
Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
GCC
Israel
Rest of Middle East
9. Competitive Landscape
Heat Map Analysis
Company Profiles
Roche AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Illumina, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Natera Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Laboratory Corporation of America Holding
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Qiagen N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Thermo Fisher Scientific
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Exact Sciences Corp.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Biocept, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Genomic Health Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Guardant Health
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
CareDx Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Adaptive Biotechnologies Corporatio
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Biocartis SA.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 48 market data tables and 57 figures on "Liquid Biopsy Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook